Disease-modifying antirheumatic drugs (DMARDs) are a class of medications used to slow the progression of rheumatoid arthritis and other autoimmune diseases by targeting the underlying processes causing inflammation and joint damage. Unlike NSAIDs or corticosteroids, DMARDs not only alleviate symptoms but also modify the disease course, potentially improving long-term outcomes and quality of life for patients.